Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases. The company is driven by a mission to discover, develop, and provide innovative products and services that save and improve lives around the world. Merck delivers vaccines, medications, and consumer and animal health products that can help millions around the world. Merck was founded in 1891 and is headquartered in Kenilworth, NJ.

Research Grants 740 show all


$17M
2015

$37.7M
2016

$61.8M
2017

$9.1M
2018

$36.2M
2019

Publications 14,868 show all

  • 206
    Enzyme Inhibitors/pharmacology
  • 167
    Chromatography, High Pressure Liquid/methods
  • 164
    Drug Design
  • 141
    Diabetes Mellitus, Type 2/drug therapy
  • 129
    Anti-Bacterial Agents/pharmacology
  • 111
    Mass Spectrometry/methods
  • 99
    Drug Discovery
  • 99
    Pyridines/pharmacology
  • 93
    Piperidines/pharmacology
  • 89
    Pharmaceutical Preparations/metabolism

Patents 66,915show all

  • 20,994
    C07D - Heterocyclic compounds
  • 11,805
    A61K - Preparations for medical, dental, or toilet purposes
  • 5,523
    C07C - Acyclic or carbocyclic compounds
  • 4,072
    C07K - Peptides
  • 2,331
    C12N - Microorganisms or enzymes
  • 2,281
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 1,767
    C07J - Steroids
  • 1,514
    C07H - Sugars
  • 1,474
    C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
  • 1,054
    G01N - Investigating or analysing materials by determining their chemical or physical properties

Clinical Trials 6,324show all

2,267Phase 31,154Phase 2952N/A690Phase 1546Phase 4261Other

SEC Filings show all


218
8-K

79
10-Q

26
10-K

Contact Information

2000 Galloping Hill Road
Kenilworth, NJ 07033
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$5,586,00010000+2018-11-25Ipo

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2016-01-21$5,000,000Series UnknownGavi, the Vaccine Alliance
2018-11-25$586,000Post Ipo EquityPrivate Capital Advisors